Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford surgeons have devised a course to train healthcare providers in Africa to effectively treat children with clubfoot in under resourced situations.

Baby with clubfoot.

More than 30,000 children in Africa are born with clubfoot each year. Many thousands of these children will not receive treatment, as it is not available where they live.

 

We are very excited by the opportunity to completely change the lives of children and families, by training many more healthcare providers to treat more children with clubfoot. - Professor Chris Lavy

Without treatment, the condition becomes 'neglected clubfoot', a painful and severely disabling deformity. However, in up to 95% of cases, clubfoot can be treated successfully using the Ponseti method, especially if this is initiated early. The Ponseti method involves gentle manipulations of the foot and serial plaster casting over a period of about six weeks, then a very small outpatient procedure to divide a tight tendon. The child then needs to wear a brace for a short time to prevent recurrence.

We are raising £100,000 to deliver clubfoot training to healthcare providers in Africa, transforming the lives of thousands of children across the continent.

Professor Chris Lavy, at the University of Oxford, has worked with children with clubfoot for the last 20 years, both in the UK and Africa. He currently leads the Africa Clubfoot Training Project, a project that is strengthening training and delivery capacity for clubfoot treatment in 18 countries in sub-Saharan Africa, helping more children have access to much needed clubfoot treatment.

Chris says: "We are very excited by the opportunity to completely change the lives of children and families, by training many more healthcare providers to treat more children with clubfoot."

Researchers, surgeons, and physiotherapists from the University of Oxford and the Nuffield Orthopaedic Centre have developed two courses for healthcare professionals - one to train providers to delivering treatment to children with clubfoot, and one to train new instructors.

Working with our partners across Africa, we devised a two-day Basic Clubfoot Treatment Provider training course based on the Ponseti technique, and designed especially for under-resourced situations.

In many African countries there are shortages of healthcare providers, and our course focuses on key essentials to accommodate this reality. We have shown that healthcare providers who have no specialised physiotherapy or orthopaedic training can effectively deliver treatment for clubfoot.

Our Clubfoot 'Train The Trainer' course addresses the shortage of healthcare providers further. It trains new instructors in the knowledge and skills necessary to teach the basic course.

We aim to give every child with clubfoot the opportunity to have treatment, as we roll out two courses across Africa, a Basic Clubfoot Treatment Provider training course and a Clubfoot 'Train The Trainer' course.

The 4-week campaign runs from Monday 7 November to Sunday 4 December, at https://oxreach.hubbub.net/p/clubfoot/.

Support us

DONATE HERE.

The 4-week campaign runs from Monday 7 November to Sunday 4 December.

 

SPREAD THE WORD

On Twitter @ndorms #africaclubfoot

On Facebook

Tell all your friends, family, acquaintances.

 

BIG BIG BIG THANK YOU!

 

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Professor Michael Dustin elected to the National Academy of Sciences

Awards Kennedy Main

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.